| Literature DB >> 28986581 |
László Imre1, Zoltán Simándi2,3, Attila Horváth2, György Fenyőfalvi1, Péter Nánási1, Erfaneh Firouzi Niaki1, Éva Hegedüs1, Zsolt Bacsó1, Urbain Weyemi4, Rebekka Mauser5, Juan Ausio6, Albert Jeltsch5, William Bonner4, László Nagy2,3,7, Hiroshi Kimura8, Gábor Szabó9.
Abstract
Current approaches have limitations in providing insight into the functional properties of particular nucleosomes in their native molecular environment. Here we describe a simple and powerful method involving elution of histones using intercalators or salt, to assess stability features dependent on DNA superhelicity and relying mainly on electrostatic interactions, respectively, and measurement of the fraction of histones remaining chromatin-bound in the individual nuclei using histone type- or posttranslational modification- (PTM-) specific antibodies and automated, quantitative imaging. The method has been validated in H3K4me3 ChIP-seq experiments, by the quantitative assessment of chromatin loop relaxation required for nucleosomal destabilization, and by comparative analyses of the intercalator and salt induced release from the nucleosomes of different histones. The accuracy of the assay allowed us to observe examples of strict association between nucleosome stability and PTMs across cell types, differentiation state and throughout the cell-cycle in close to native chromatin context, and resolve ambiguities regarding the destabilizing effect of H2A.X phosphorylation. The advantages of the in situ measuring scenario are demonstrated via the marked effect of DNA nicking on histone eviction that underscores the powerful potential of topological relaxation in the epigenetic regulation of DNA accessibility.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28986581 PMCID: PMC5630628 DOI: 10.1038/s41598-017-12608-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 4Superhelicity relaxation induced nucleosome destabilization. (A and B) Comparison of the changes of superhelicity (A) and nucleosome destabilization (B) in the case of the intercalator SYBR Gold, in Jurkat cells. (A) Determination of the relaxation concentration of SYBR Gold. The average halo radius of G1 phase cells was measured at increasing dye concentrations and in the presence of different salt concentrations (see “winding assay” in Methods). The inset shows the principle of the nuclear halo winding assay: As the intercalator concentration increases, the negatively supercoiled DNA loops get relaxed (halo size is increased), then overwound (i.e. becoming positively supercoiled with a decreased halo size). (B) Histone elution using SYBR Gold at 0.75 M NaCl. The SYBR Gold concentration inducing complete halo relaxation at 0.75 M NaCl concentration and where the DNA loops are completely relaxed is shown by the dashed line on both panels. (See also: Supplementary Fig. S8A) The concentration of the intercalators are shown in a logarithmic scale. Normalization was as described in the Methods. (C and D) Effect of nickase (C) and DNase I (D) treatment on H2A.X salt elution in HCT116 nuclei. (See also: Supplementary Fig. S8C and D). (E and F) Effect of nickase (E) and DNase I (F) treatment on H2A salt elution in HCT116 nuclei. (See also: Supplementary Fig. S8E and F). The elution curves refer to G1 phase cells gated according to their DNA fluorescence intensity distribution. Error bars represent SEM of ~600 G1 nuclei measured by LSC.
Figure 2EBr induced nucleosome destabilization. (A) EBr induced elution of H2B-GFP and H3-GFP performed on ice and at room temperature (RT) in histone-GFP expressor HeLa nuclei. EBr was applied in the presence of 0.75 M NaCl. (B) Effect of co-treatment with EBr and salt in histone-GFP expressor HeLa nuclei. The shift of elution curves in the presence of 100 µg/ml EBr is seen comparing the continuous and dashed lines. The blue double arrow shows that the maximal effect of EBr on nucleosome stability occurs at 0.75 M salt. (C) EBr elution profiles of H3K4me3 or H3K27me3 in HeLa nuclei. (See also: Supplementary Fig. S1F). (D) EBr elution profiles of H3K4me3 or H3K27me3 in mES and NPC nuclei. (See also: Supplementary Fig. S2). The concentration of the intercalators are shown in a logarithmic scale in panels A, C and D. The elution curves refer to G1 phase cells gated according to their DNA fluorescence intensity distribution and the error bars represent SEM of ~600 G1 nuclei measured by LSC. The cell-to-cell and sample-to-sample C.V. values of the elution profiles are shown in Supplementary Table S1.
Figure 3Salt induced nucleosome destabilization. (A) Salt elution profiles of antibody detected H2A, of H2B-GFP, H3-GFP and H4-GFP in histone-GFP expressor HeLa nuclei. (B) Salt elution profiles of γH2A.X, H2A.X and H2A, measured in parallel, in the nuclei of HCT116 cells exposed to 25 μM etoposide. (See also: Supplementary Fig. S6). (C) Salt elution profiles of H3K4me3 and H3K27me3 in HeLa nuclei. (See also: Supplementary Fig. S7). (D) Salt elution profiles of H3K4me3 and H3K27me3 in mES and NPC nuclei (See also: Supplementary Fig. S2). The elution curves refer to G1 phase cells gated according to their DNA fluorescence intensity distribution and the error bars represent SEM of ~600 G1 nuclei measured by LSC. The cell-to-cell and sample-to-sample C.V. values of the elution profiles are shown in Supplementary Table S1.
Figure 1Doxorubicin induced eviction of nucleosomes. (A) Flow-chart of the method. Histones remaining in the nuclei after treatment with increasing concentration NaCl or intercalator solutions were detected by indirect immunofluorescence labeling and quantitatively analyzed by laser scanning cytometry (LSC). (B) Immunofluorescence intensity distribution histograms of H3K4me3 in the nuclei of control (blue) and doxorubicin treated G1 phase HeLa cells, using the following concentrations of the drug: 9 μM (magenta), 18 μM (light blue) and 36 μM (red). Integral fluorescence values for ~600 G1 nuclei were measured by LSC. Doxorubicin treatment was performed on live H3-GFP cells. The means of the H3-GFP signal (not shown in this panel) are plotted together with those of immunofluorescence on panel C. (C) Elution profiles constructed from the fluorescence distribution histograms generated by LSC. The curves demonstrate the decreasing levels of chromatin bound H3K4me3 (according to the color code used on panel B) and of the H3-GFP, used as internal reference, as a function of doxorubicin concentration. (D) H3K4me3 immunofluorescence staining of mES nuclei: representative CLSM images recorded at two magnifications, before (control) and after doxorubicin (intercalator) treatment. (E) ChIP-Seq density profiles of samples treated with 18 μM doxorubicin. H3K4me3 ChIP-seq analyses were performed in two technical replicates of the doxorubicine treated (red) and control (blue) samples. Anchor-plots of H3K4me3 sites around transcription start sites (TSSs; left) and around H3K4me3 positive non-TSS sites (right) are shown. ChIP-Seq signals were plotted in a ± 4 kb window. The Y axis shows the averaged read counts of the detected regions (tags normalized to 10 million). (See also: Supplementary Fig. S1A). (F and G, top) H3K4me3 genome browser images for two gene pairs expressed (F; Pou5f1 and PRMT1), and non-expressed (G; Tubb3 and PRMT8) in mES selected based on mES RNA-seq data (PRJNA302640). (F and G, bottom) ChIP-qPCR validation of the ChIP-Seq results shown in panel E at different doxorubicin concentrations (0 μM (ctrl), 6 μM, 9 μM and 18 μM; indicated by the gradient shape below the bar charts). Chromatin Immunoprecipitate (ChIP)/input ratios (referring to H3K4me3 vs mock IgG) are shown. (See also: Supplementary Fig. S1B–D).
Comparison of QINESIn with other methods available for the examination of molecular features related to nucleosome stability.
| QINESIn | Proteomic analyses Refs (A) | Assays on isolated/reconstituted nucleosomes Refs (B) | Genomics approaches Refs (C) | Plasmid derived tagged histones Refs (D) | |
|---|---|---|---|---|---|
| Quantitative analysis of nucleosome stability | + | + | + | + | + |
| Histone PTM specificity | + | + | + − | + | − |
| Histone variant specificity | + | + | + | + | + |
| Overall expression or modification levels assessed | + | + | − | + − | − |
| Measurement targets endogenous histones | + | + | + | + | − |
| Measurement of nucleosome stability | + | − | − | − | + |
| Analyses according to cell cycle phases, without synchronization* | + | − | − | − | − |
| Assessment of superhelicity effects | + | − | − | − | − |
| Detection of molecular interactions by X-linking*** | + | − | − | − | + |
| High-throughput screening | + | − | − | − | − |
| Comparison of different cell types in mixed-cell experiments**** | + | − | − | − | − |
| Analysis according to cell surface markers in mixed-cell experiments | + | − | − | − | − |
| Cell-by-cell analyses | + | − | − | − | + |
| Sensitivity to heterogeneity (e. g. gating for different expression levels)***** | + | − | − | − | + |
| Picturing genome-wide distribution | − | − | − | + | − |
“+” indicates that the particular approach has proved to be applicable for the corresponding purposes listed in the left column. “+/−” indicates that the particular approach provides semiquantitative or not readily extractable information. The asterisks refer to the data demonstrating the QINESIn features: *Supplementary Fig. S12; **Fig. 4C–F; Supplementary Fig. S10A; ***Supplementary Fig. S13 A,B; ****Figs 2D, 3D, Supplementary Fig. S2; *****Supplementary Fig. S11A,B. References: (A):[27,28,38,39,43], (B):[2,18–26,32–37,45], (C):[29–31,46], (D):[40–44].